Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists represent a significant advancement in weight loss treatment, with semaglutide and tirzepatide receiving FDA approval specifically for weight management in adults with obesity or overweight with weight-related conditions. Clinical trials demonstrate that GLP-1 agonists can produce weight reductions of 15-22% of body weight when combined with lifestyle changes. PlexusDx provides access to personalized GLP-1 therapy tailored to your unique metabolic profile, without the need for insurance or membership fees.
FDA Approval of GLP-1 Medications for Weight Loss
GLP-1 receptor agonists were originally developed to treat type 2 diabetes by regulating blood sugar levels. In recent years, the FDA expanded approval for these medications specifically for chronic weight management in individuals with obesity or overweight status combined with at least one weight-related health condition. Semaglutide (marketed as Wegovy for weight loss) and tirzepatide (marketed as Zepbound) both received FDA approval for weight loss indications based on robust clinical trial data showing significant reductions in body weight.
The approval process for weight-loss medications involves rigorous testing to demonstrate both safety and efficacy in real-world patient populations. These approvals represent recognition that GLP-1 agonists address the underlying biology of appetite regulation and weight control rather than simply suppressing hunger through stimulation. The FDA continues to monitor long-term safety data from ongoing studies and real-world use to ensure these medications maintain favorable benefit-risk profiles for patients seeking sustainable weight reduction.
How GLP-1 Agonists Work for Weight Management
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that your body produces after eating. This hormone signals your brain that you are satisfied, slows the rate at which your stomach empties, and helps regulate blood sugar levels. GLP-1 receptor agonists mimic this natural hormone by binding to GLP-1 receptors throughout your body, enhancing your body's natural appetite-control signals and promoting feelings of fullness with smaller meal portions.
The mechanism of weight loss involves multiple biological pathways working in concert. When GLP-1 agonists activate receptors in the hypothalamus—the brain region controlling hunger and satiety—you experience reduced food cravings and increased satisfaction from eating less. Additionally, these medications may increase energy expenditure and alter your relationship with high-calorie foods, making it easier to maintain a calorie deficit without the constant struggle against hunger that characterizes many traditional diet approaches.
Clinical Evidence Supporting GLP-1 Effectiveness
Multiple large-scale clinical trials have documented the weight loss effectiveness of GLP-1 agonists. The STEP trials evaluating semaglutide demonstrated that participants receiving the medication lost an average of 15-18% of their baseline body weight over 68 weeks, compared to 2-3% in the placebo group. The SURMOUNT trials for tirzepatide showed even more substantial results, with participants losing 19-22% of their body weight, making these among the most effective weight-loss interventions available outside of bariatric surgery.
Beyond weight reduction alone, clinical studies show that GLP-1 agonists improve multiple cardiometabolic risk factors including blood pressure, cholesterol levels, and inflammation markers. Participants in these trials also reported improvements in quality of life, mobility, and ability to engage in physical activities. These broader health benefits extend the value of GLP-1 therapy beyond the number on the scale, addressing the systemic health consequences of obesity.
Personalized GLP-1 Therapy with PlexusDx Precision Testing
While GLP-1 agonists are effective for many patients, individual responses vary based on genetic factors and metabolic pathways. PlexusDx offers the Precision Peptide Genetic Test, which evaluates your genetic variants in key pathways including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—markers that influence how your body responds to GLP-1 therapy and weight management interventions. This test maps 14 distinct biological pathways and evaluates 49 different peptides to reveal your unique metabolic predispositions.
With genetically informed insights, your PlexusDx provider can select and personalize your GLP-1 therapy to match your individual biology rather than using a one-size-fits-all approach. PlexusDx compounds medications in licensed 503A pharmacies and offers multiple options including semaglutide injection starting at $149/month, oral semaglutide, tirzepatide injection, and combination therapies. Your dose may need to go up as your body adapts, but your price remains flat—ensuring predictable, affordable access to personalized weight loss treatment across all 50 states.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide FDA-approved for weight loss?
Yes, semaglutide is FDA-approved for chronic weight management under the brand name Wegovy. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, providing the same active ingredient in a more affordable format starting at $149/month with no insurance required.
What percentage of weight loss can I expect with GLP-1 therapy?
Clinical trials show average weight loss of 15-22% of baseline body weight with GLP-1 agonists over 12-18 months when combined with lifestyle changes. Individual results vary based on genetics, adherence, diet, and exercise. PlexusDx's Precision Peptide Genetic Test can help predict your likely response based on your genetic profile.
How much does GLP-1 treatment cost at PlexusDx?
PlexusDx offers compounded semaglutide injection starting at $149/month with flat pricing across all dose levels—your dose may increase over time, but your monthly price won't. All medications are HSA/FSA eligible, and PlexusDx serves all 50 states with no insurance requirement or membership fees.
Are there side effects with GLP-1 medications?
Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and improving over time as your body adjusts. Serious side effects are rare but may include pancreatitis or gallbladder issues. Your PlexusDx provider will monitor your response and adjust your treatment plan to minimize discomfort while maximizing results.
How does the Precision Peptide Genetic Test help with GLP-1 therapy?
The Precision Peptide Genetic Test ($99 add-on after your first month) identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes, revealing how your body metabolizes GLP-1 medications and responds to weight loss interventions. This allows PlexusDx providers to personalize your therapy choice, dosing strategy, and complementary treatments based on your unique peptide pathways rather than guessing.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What to Expect with Semaglutide Injections for Weight Loss
How Long Does Ozempic Take to Work for Weight Management and Blood Sugar Control?